ABN AMRO GROUP NV-CVA/ NL0011540547 /
24.06.2024 10:22:32 | Изменение +0.05 | Объем сделки | Бид- | Предложение- | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
15.50EUR | +0.32% | 16,417 Оборот: 253,870.16 |
-Величина цены спроса: - | -Величина цены предложения: - | 13.52 млрдEUR | 9.74% | 5.19 |
GlobeNewswire
10:30
REPEAT – Metasphere Labs Enters a Definitive Agreement with ARCannabis to Develop VR Virtual Store
GlobeNewswire
10:00
OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
9:53
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Cla...
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница